Performance Assessment of a Modified Daily Disposable Contact Lens
NCT ID: NCT03762668
Last Updated: 2020-01-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2018-12-03
2019-01-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear
NCT01669629
Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 1
NCT04527978
Evaluation of the Performance of Different Daily Disposable Lens Designs in Habitual Soft Contact Lens Wearers
NCT04668989
A Comparative Study of Two Daily Disposable Contact Lenses in Higher Myopia Subjects
NCT02066922
Evaluation of Delefilcon A Contact Lenses
NCT06884202
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MDACL, then DACL
Modified delefilcon A contact lenses (MDACL) worn first, followed by delefilcon A contact lenses (DACL), as randomized. Each product worn bilaterally (in both eyes) for approximately 1 week in a daily disposable modality.
Modified delefilcon A contact lenses
Spherical soft daily disposable contact lens
Delefilcon A contact lenses
Spherical soft daily disposable contact lens
DACL, then MDACL
DACL worn first, followed by MDACL, as randomized. Each product worn bilaterally for approximately 1 week in a daily disposable modality.
Modified delefilcon A contact lenses
Spherical soft daily disposable contact lens
Delefilcon A contact lenses
Spherical soft daily disposable contact lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modified delefilcon A contact lenses
Spherical soft daily disposable contact lens
Delefilcon A contact lenses
Spherical soft daily disposable contact lens
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current wearer of commercial DAILIES TOTAL1 Contact Lenses in both eyes;
Exclusion Criteria
* Any eye surgery that contraindicates contact lens wear, as determined by the Investigator;
* Wears habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week)
* Monocular (only one eye with functional vision);
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sr. CDMA Project Lead, Vision Care
Role: STUDY_DIRECTOR
Alcon Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Investigative Site
Maitland, Florida, United States
Alcon Investigative Site
Orlando, Florida, United States
Alcon Investigative Site
West Palm Beach, Florida, United States
Alcon Investigative Site
Ann Arbor, Michigan, United States
Alcon Investigative Site
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLP691-C002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.